Not sure the statistics agree with you on that .... especially given another 1,847 people died on Tuesday 4th Jan from COVID-19 in the USA alone ?
I think Mesoblast have a great case to lobby either the NIH or a new partner to fund this additional phase 3 COVID-19 ARDS trial that they propose to undertake this year ....
..... almost 4 million new COVID-19 cases in the last 7 days is likely to see hospitalisation and death numbers increase over the coming weeks based on previous lags from case number increases and the situations evolving in many states combined with the winter months now upon the USA
I am all for the additional phase 3 COVID-19 ARDS trial as long as Mesoblast don't have to fund it
https://www.worldometers.info/coronavirus/
![]()
https://www.worldometers.info/coronavirus/weekly-trends/#weekly_table
![]()
- Forums
- ASX - By Stock
- MSB
- RWE for 2nd MSB COVID-19 ARDS P3 Trial
MSB
mesoblast limited
Add to My Watchlist
1.80%
!
$1.70

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-4
-
- There are more pages in this discussion • 666 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.70 |
Change
0.030(1.80%) |
Mkt cap ! $2.172B |
Open | High | Low | Value | Volume |
$1.67 | $1.74 | $1.67 | $6.647M | 3.897M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 44280 | $1.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.70 | 26847 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 44280 | 1.690 |
4 | 54367 | 1.680 |
3 | 34371 | 1.675 |
1 | 6718 | 1.670 |
5 | 88100 | 1.660 |
Price($) | Vol. | No. |
---|---|---|
1.700 | 26847 | 2 |
1.705 | 13250 | 2 |
1.715 | 5539 | 1 |
1.720 | 12648 | 3 |
1.725 | 22531 | 3 |
Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online